2024-03-28T20:35:26Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_867DFDC10223
2024-03-23T02:38:19Z
serval:BIB_867DFDC10223
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
10.1016/j.radonc.2017.12.028
000433102000015
29373196
Atalar
B.
author
Ozsahin
M.
author
Call
J.
author
Napieralska
A.
author
Kamer
S.
author
Villa
S.
author
Erpolat
P.
author
Negretti
L.
author
Lassen-Ramshad
Y.
author
Onal
C.
author
Akyurek
S.
author
Ugurluer
G.
author
Baumert
B.G.
author
Servagi-Vernat
S.
author
Miller
R.C.
author
Ozyar
E.
author
Sio
T.T.
author
article
2018-04
Radiotherapy and oncology
1879-0887
0167-8140
journal
127
1
96-102
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Cerebellar Neoplasms/mortality
Cerebellar Neoplasms/pathology
Cerebellar Neoplasms/surgery
Cerebellar Neoplasms/therapy
Chemoradiotherapy, Adjuvant
Cisplatin/administration & dosage
Craniospinal Irradiation
Disease-Free Survival
Europe/epidemiology
Female
Humans
Male
Medulloblastoma/mortality
Medulloblastoma/pathology
Medulloblastoma/surgery
Medulloblastoma/therapy
Middle Aged
Multivariate Analysis
Prognosis
Retrospective Studies
Treatment Outcome
United States/epidemiology
Vincristine/administration & dosage
Young Adult
Adult medulloblastoma
Chemotherapy
Craniospinal
Multimodality
Radiotherapy
Rare Cancer Network (RCN)
eng
60_published
peer-reviewed
Publication types: Journal Article ; Multicenter Study
Publication Status: ppublish